Avoiding Open Heart Surgery

A medical breakthrough in cardiac care for Americans too ill or frail for open-heart surgery is showing significant promise. The new FDA-approved medical device called Core Valve, was tested in clinical trials as a treatment option for people with severe aortic stenosis who are unable to undergo surgery, and could die without treatment. Dr. Michael Reardon, a cardiac surgeon from Houston Methodist Hospital in Texas joins us now with more about this device and its impact.

Dr. Michael, M.D. Reardon grew up in Houston, Texas, where he attended Baylor College of Medicine. He completed a 5 year general surgery residency under Dr. Michael DeBakey in the Baylor Affiliated Hospitals and a 2 year cardiothoracic residency under Dr. Denton Cooley at the Texas Heart Institute.

He has started and run his own private practice as well as served on the full time faculty of Baylor College of Medicine where he was Professor of Surgery and Chief of Cardiothoracic Surgery, and Program Director for the Thoracic Surgery Residency and Vice Chair of Academic Affairs in the Department of Surgery. He has spent his entire career at The Methodist Hospital serving in numerous administrative positions including President of the Medical Staff.

He currently is Weill Cornell Professor of Cardiothoracic Surgery, Senior Attending Surgeon at The Methodist Hospital and Clinical Professor of Cardiothoracic Surgery at M.D. Anderson Cancer Center. He serves as Medical Director of the Fondren Brown Cardiovascular Operating Rooms, , Medical Director of the Nurse Practitioner Program and business officer of the physician organization at The Methodist Hospital. He has written over 300 medical and scientific papers, book chapters and abstracts and frequently lectures on his research and clinical interests of cardiac valvular disease, thoracic aortic disease and cardiac tumors. In 1998 Dr. Reardon performed the first successful autotransplant worldwide for a malignant left atrial sarcoma and the first successful autotransplant for a malignant left ventricular sarcoma in 2003. Since then, Dr. Reardon has performed more than 28 such successful surgeries has traveled to Poland and Israel to perform these surgeries with great success and is recognized as the leading surgeon in his field.

More Stories

Latest News